Hemostasis, LLC acquired Fiagon AG Medical Technologies from Intersect ENT, Inc.
Hemostasis, LLC completed the acquisition of Fiagon AG Medical Technologies from Intersect ENT, Inc. on May 13, 2022.
1st Jan change | Capi. | |
---|---|---|
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 68.11B | |
+2.39% | 50.53B | |
+9.36% | 44.8B | |
+2.84% | 40.7B | |
+24.51% | 32.25B | |
+3.43% | 26.53B | |
+15.25% | 25.02B |